oropouch
viru
oro
famili
bunyavirida
second
frequent
caus
arbovir
febril
ill
brazil
studi
conduct
understand
oro
entri
hela
cell
chlorpromazin
inhibit
earli
step
oro
replic
cycl
consist
entryunco
data
indic
oro
enter
hela
cell
clathrinco
vesicl
mechan
suscept
endosom
acidif
inhibitor
transmiss
electron
microscopi
immunofluoresc
indic
oro
associ
clathrinco
pit
found
associ
late
endosom
time
shorter
h
elsevi
bv
right
reserv
oropouch
oro
emerg
zoonot
viru
famili
bunyavirida
genu
orthobunyaviru
serogroup
simbu
schmaljohn
hooper
circul
wild
anim
mainli
sloth
caus
human
epidem
urban
area
tropic
south
america
raini
season
prolifer
insect
vector
especi
bite
midg
culicoid
paraensi
facilit
transmiss
viru
anim
reservoir
human
host
rapid
spread
popul
villag
town
signific
public
health
impact
human
infect
clinic
character
fever
myalgia
headach
arthralgia
skin
rash
malais
may
long
last
pinheiro
et
al
oro
fever
regist
almost
exclus
amazon
global
warm
deforest
redistribut
vector
reservoir
increas
risk
oro
spread
other
area
america
mani
virus
subvert
host
cell
endocyt
pathway
entri
rout
process
trigger
receptor
bind
endocytosi
within
clathrinco
acid
vesicl
brodski
et
al
pivot
entryunco
jc
west
nile
virus
human
rhinoviru
type
chu
ng
pho
et
al
snyer
et
al
uptak
within
caveola
describ
simian
viru
coronaviru
nomura
et
al
stang
et
al
littl
known
entri
mechan
oro
describ
studi
conduct
understand
oro
enter
hela
cell
oro
inocul
onto
monolay
hela
cell
moi
adsorb
c
h
wash
five
time
pb
incub
c
differ
time
postinfect
cell
fix
glutaraldehyd
cacodyl
buffer
ph
postfix
osmium
tetroxid
cacodyl
buffer
h
dehydr
ethanol
stain
uranyl
acet
embed
emb
em
hatfield
pa
thin
section
poststain
lead
citrat
uranyl
acet
orolik
particl
observ
em
associ
clathrinco
pit
fig
hela
cell
monolay
prepar
mm
coverslip
inocul
oro
moi
absorb
c
h
coverslip
wash
three
time
pb
replenish
mem
fetal
bovin
serum
fb
incub
c
min
fix
paraformaldehyd
sigma
cell
permeabil
triton
sigma
pb
block
gml
donkey
igg
pb
bsa
coverslip
incub
mixtur
goat
anticlathrin
heavi
chain
santa
cruz
santa
cruz
ca
mous
antioro
polyclon
chlorpromazin
sigma
st
loui
mo
agent
block
clathrindepend
endocytosi
pho
et
al
subtil
et
al
wang
et
al
inhibit
oro
replic
hela
cell
dosedepend
fashion
gml
significantli
reduc
viru
replic
without
signific
cytotox
figur
transferrin
uptak
known
clathrindepend
therefor
transferrin
conjug
texa
red
invitrogen
carlsbad
ca
use
control
effect
chlorpromazin
figur
chlorpromazin
time
addit
assay
oro
inocul
onto
hela
cell
monolay
moi
adsorb
c
h
cell
wash
five
time
cold
pb
replenish
fresh
mem
fb
incub
c
h
chlorpromazin
ad
hela
cell
cultur
gml
h
time
viru
inocul
h
postinfect
h
cell
supernat
harvest
separ
viru
titrat
cpe
detect
quadrupl
monolay
vero
cell
inocul
decim
serial
dilut
tcid
chlorpromazin
inhibit
oro
product
ad
h
h
accumul
progeni
viru
close
control
level
drug
ad
h
postinfect
indic
chlorpromazin
inhibit
oro
product
initi
phase
viru
cycl
consist
clathrindepend
mechan
entryunco
fig
endocytosi
caveola
depend
cholesterolrich
domain
anderson
jacobson
couet
et
al
nabi
le
shin
abraham
nystatin
sigma
bind
cholesterol
high
affin
pucadyil
et
al
cell
treat
drug
defici
caveolindepend
endocytosi
pma
sigma
also
inhibit
caveola
activ
phosphokinas
c
pkc
caveola
inhibitori
effect
nystatin
pma
hela
cell
confirm
use
cholera
toxin
b
subunit
ctb
posit
control
figur
inhibit
oro
nystatin
pma
test
follow
protocol
use
chlorpromazin
except
pma
incub
carri
h
pma
inhibit
oro
product
even
use
concentr
high
gml
fig
suggest
oro
entri
independ
caveola
nystatin
inhibit
oro
dosedepend
fashion
gml
significantli
reduc
viru
product
neither
nystatin
pma
signific
cytotox
figur
time
addit
assay
show
nystatin
inhibit
oro
product
ad
h
prior
time
oro
infect
howev
oro
titer
supernat
return
control
level
even
drug
ad
late
h
postinfect
fig
remark
signific
accumul
infecti
intracellular
viru
continu
observ
oro
titer
supernat
remain
low
suggest
addit
cholesterolrich
domain
associ
caveola
nystatin
may
inhibit
cholesteroldepend
process
like
constitut
exocytosi
salaun
et
al
may
involv
later
step
oro
replic
cycl
inhibitor
endosom
acidif
chloroquin
bafilomycin
sigma
respect
gml
nm
reduc
oro
product
without
signific
cytotox
figur
chloroquin
bafilomycin
inhibit
endosom
acidif
hela
cell
confirm
experi
lysotrack
figur
time
addit
assay
chloroquin
bafilomycin
concentr
inhibit
oro
product
hela
cell
ad
h
prior
time
infect
oro
titer
tend
resum
control
level
drug
ad
subsequ
time
fig
suggest
oro
entri
requir
acid
compart
probabl
uncoat
look
oro
entri
pathway
hela
cell
monolay
prepar
coverslip
inocul
oro
moi
adsorb
c
h
incub
min
c
fix
paraformaldehyd
sigma
eea
marker
earli
late
endosom
respect
coloc
oro
observ
coloc
oro
indic
viru
reach
late
endosom
less
h
fig
despit
import
public
health
tropic
south
america
virtual
noth
known
cell
biolog
oro
replic
studi
show
oro
enter
hela
cell
associ
clathrinco
pit
acidificationdepend
endocyt
pathway
reach
late
endosom
less
h
result
agreement
previous
publish
data
entri
mechan
bunyavirida
hantaan
viru
also
enter
cell
clathrindepend
mechan
requir
low
ph
jin
et
al
also
suggest
uukuniemi
california
enceph
virus
requir
low
ph
entri
hacker
et
al
ronka
et
al
reason
investig
inhibitor
endosom
acidif
possibl
adjuv
therapi
oro
infect
indebt
maria
tereza
pianoto
maglia
maria
dolor
sealbra
ferreira
augusto
maulin
marcia
sirlen
zardin
graeff
technic
support
dr
joao
k
kajiwara
help
suggest
effect
drug
replic
oro
gml
chlorpromazin
gml
nystatin
b
gml
chloroquin
c
nm
bafilomycin
ad
hela
monolay
differ
time
rel
infect
start
h
continu
differ
time
postinfect
oro
pma
inhibit
oro
replic
e
therefor
time
addit
assay
carri
drug
